Print page

Packaging Resource Center

Split Decisions: Tablet Scoring Under More Scrutiny
FDA provides more direction as questions arise about dosage consistency.

Serialization & Traceability: Where Pharma Stands
A new survey sheds light upon choices and challenges.

Can Drug Manufacturers Find Business Benefits in Product Serialization?
John Danese, Oracle’s Director of Product Strategy, provides an update on the electronic pedigree landscape and how manufacturers are doing in their serialization efforts.

Pedigree Adopters Play the Waiting Game
Manufacturers’ electronic pedigree and serialization efforts creep ahead, slowed by FDA’s inaction.

More Articles »

White Papers: In Depth Research

The New Approach to Track and Trace
Author: Cognex Corp.
Posted: 06/14/2010
A new leaner, more cost-effective approach to track and trace demands new technology. Due to advances in the power of digital signal processors (DSP), imaging sensors and decoding algorithms, traceability applications such as ID code reading, text verification, mark quality assessment, and label inspection can now be accomplished more economically using the latest generation of smart camera vision systems.

Increasing Tablet Press Productivity Using Segmented Turret Technology
Author: Fette America
Posted: 04/15/2010
Surveys of tablet press users reveal that machines with segmented turrets increase output and reduce set-up and cleaning time over conventional presses and previous turret technologies. This paper will discuss survey data from drug manufacturers using the technology and quantify some of the benefits over conventional press technologies.

Brandjacking Index: Online Risks in Pharmaceutical Market
Author: MarkMonitor
Posted: 11/13/2009
Buying drugs online continues to be fraught with fraudsters and continues to be popular because of the high demand for inexpensive medicines. While tracking six different drug brands in July 2009, four of which were patented, MarkMonitor observed continued growth in the online market for pharmaceuticals including high levels of traffic to suspicious online pharmacies and increased numbers of listings for pharmaceuticals on B2B exchange sites.

Tales from the Counterfeiting Front: USP’s Drug Quality Matrix
Author: USP
Posted: 10/30/2009
USP has released an updated version of its matrix tracking public reports of counterfeit and substandard drugs worldwide. The report is more anecdotal than comprehensive—there’s no way to chronicle all incidents—but tells a vivid story of the challenges facing local authorities worldwide in battling counterfeits. Also, read here about how USP and USAID are ramping up their counterefforts.

More White Papers »